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Macrophages are essential players in the process of fracture healing, acting by
remodeling of the extracellular matrix and enabling vascularization. Whilst activated
macrophages of M1-like phenotype are present in the initial pro-inflammatory phase
of hours to days of fracture healing, an anti-inflammatory M2-like macrophage
phenotype is supposed to be crucial for the induction of downstream cascades of
healing, especially the initiation of vascularization. In a mouse-osteotomy model, we
provide a comprehensive characterization of vessel (CD31+, Emcn+) and macrophage
phenotypes (F4/80, CD206, CD80, Mac-2) during the process of fracture healing. To this
end, we phenotype the phases of vascular regeneration—the expansion phase (d1–d7
after injury) and the remodeling phase of the endothelial network, until tissue integrity
is restored (d14–d21 after injury). Vessels which appear during the bone formation
process resemble type H endothelium (CD31hiEmcnhi), and are closely connected to
osteoprogenitors (Runx2+, Osx+) and F4/80+ macrophages. M1-like macrophages are
present in the initial phase of vascularization until day 3 post osteotomy, but they are rare
during later regeneration phases. M2-like macrophages localize mainly extramedullary,
and CD206+ macrophages are found to express Mac-2+ during the expansion phase.
VEGFA expression is initiated by CD80+ cells, including F4/80+ macrophages, until day
3, while subsequently osteoblasts and chondrocytes are main contributors to VEGFA
production at the fracture site. Using Longitudinal Intravital Microendoscopy of the
Bone (LIMB) we observe changes in the motility and organization of CX3CR1+ cells,
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which infiltrate the injury site after an osteotomy. A transient accumulation, resulting
in spatial polarization of both, endothelial cells and macrophages, in regions distal to
the fracture site, is evident. Immunofluorescence histology followed by histocytometric
analysis reveals that F4/80+CX3CR1+ myeloid cells precede vascularization.
Keywords: bone regeneration, macrophage, endothelial cell, H-type vessel, intravital microscopy, LIMB, CX3CR1
myeloid cells
INTRODUCTION
Bone healing is a spatiotemporally regulated regeneration
process, ideally leading to complete restoration of the broken
bone without fibrous scar formation (1). Naturally, this
regeneration process undergoes endochondral bone formation,
if interfragmentary movements strain the fracture gap (2).
In the majority of clinical cases, fracture healing follows
the endochondral route and may be sub-divided into five
phases, namely an (i) initial pro-inflammatory phase, (ii) anti-
inflammatory phase, (iii) fibrocartilaginous or soft callus phase,
(iv) mineralization or hard callus phase and (v) remodeling
phase in which bone tissue regains its physiological shape with
a restored bone marrow cavity. While fracture healing occurs
in most cases without delay, still 5–10% of patients suffer from
delayed healing or non-union. To avoid delayed healing and
overcome non-unions, it is important to understand the finely
orchestrated processes of bone regeneration (3, 4).
Upon a fracture, the vessels get disrupted and nutrient supply
is lacking at the injury site. However, the vascular system
is essential for healing, by supplying cells with oxygen and
nutrients, removing debris and allowing the recruitment of
circulating cells. Endothelial progenitors (CD31+) migrate to the
fracture site from the bone marrow or from pre-existing vessels
of the periosteum (5–9). In earlier work, we could show that
revascularization peaks during two phases of fracture healing:
around day 7 (end of the inflammatory phase) and around day 21
(woven bone formation) in sheep (6). Drastic vascular structural
plasticity has also been shown during bone marrow regeneration
between 7 and 21 days by our group using a longitudinal
microendoscopic method at cellular resolution (10). Angiogenic
factors, such as vascular endothelial growth factor (VEGF)
are of great importance in order to induce vascularization.
Street et al. showed that the circulating plasma levels of VEGF
are highly increased in patients with fractures and that the
fibrin matrix within the fracture hematoma acts like a VEGF
reservoir (11). In addition, we reported in a previous study that
cells within the fracture hematoma exhibit upregulated VEGF
expression and secretion (12, 13). Osteoprogenitor cells also
produce VEGF as a consequence of the hypoxic environment,
leading to enhanced transcriptional activity of hypoxia-inducible
factor 1-alpha (HIF-1α) (14, 15). Buettmann et al. most recently
showed that especially the release of VEGFA by Osterix (Osx)+
osteoprogenitors/pre-osteoblasts is critical for vessel formation
during fracture healing (16). It is well-known that the crosstalk
between endothelium and bone cells is essential for the integrity
and formation of bone. Osteoblasts support the vasculature by
producing VEGF and basic fibroblast growth factor (bFGF) while
endothelial cells (ECs) provide factors that further osteoblast
differentiation and activity (17). Furthermore, pre-osteoclasts
and non-bone-resorbing osteoclasts have been described to
enhance vascularization and osteogenesis in the growth plate
area by releasing platelet-derived growth factor-BB (PDGF-BB)
or supporting vessel anastomosis (18, 19). While the production
of angiogenic factors by osteoprogenitors is well-known, there
is evidence accumulating that, conversely, endothelial cells can
also impact on bone formation, at least during bone development
(7). Bone development is initiated by blood vessel invasion,
and the arrival of osteoprogenitors. Subsequently, specialized
type H blood vessels secrete osteogenic factors, required for the
induction of bone formation and growth (20). Although the
presence of type H vessels has been reported at sites of bone
regeneration (10, 21), early events inducing the formation of
these vessels in those situations have not yet been investigated.
Next to the adaptive immunity, the importance of the
innate immune system for regenerative processes has been
shown by several studies (22–26). Macrophages have been
identified as key players for the recovery of tissue integrity
and function. Several different types of myeloid-lineage cells
can be distinguished in bone regeneration (23). Tissue-
resident macrophages (also termed osteomacs) which express
F4/80, can be found closely to bone-lining cells, and support
intramembranous bone formation as well as endochondral
ossification (22, 25, 26). Recruited immune macrophages (M1-
like/M2-like) are more pivotal in endochondral ossification,
which has been shown by Schlundt et al., who deleted
macrophages in osteotomized mice by treatment with clodronate
liposomes, and Alexander et al. who examined macrophage
subsets close to the periosteum during regeneration (24, 25).
Furthermore, osteoclasts are multinucleated tartrate-resistant
acid phosphatase (TRAP)+F4/80− myeloid cells, which derive
from fusion events (22).
In other tissues or scenarios, macrophages are essential for
vascularization and angiogenesis. They are able to degrade
extracellular matrix (ECM) and release pro-angiogenic factors.
Degradation of the ECM enables the migration of endothelial
progenitors and activates the angiogenic potential of some ECM
molecules, as has been shown for fragments of hyaluronic
acid (27). In addition, macrophages also release factors that
attract, activate or even inhibit angiogenic cells depending
on the phase of vascularization (28). Studies during mouse
development revealed the tight association of macrophages with
capillaries and the subsequent enhancement of angiogenesis
(29, 30). Macrophages have also been shown to regulate vessel
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permeability comparable to pericytes (31). Vice versa, endothelial
cells (ECs) also promote the selective growth and differentiation
of macrophages, especially the switch towards an M2-like
phenotype, which requires direct contact with the endothelium
and the regulation via macrophage colony-stimulating factor
(M-CSF) signaling (32). However, a potential crosstalk between
macrophages and ECs and the details of such interactions during
bone regeneration have not been studied so far.
Within this study, we aim to analyze the initial phases of
angiogenesis in bone healing with vascular regeneration and
their dependence on the presence of macrophages. We focus
on the early regeneration events, until the shift from pro-
to anti-inflammatory phase, where a close crosstalk of blood
vessels with macrophages is most prominent (d1–d7 after injury)
and compare this to the bone remodeling phase driven by
osteoprogenitors and mineralized tissue formation (d14–d21
after injury).
METHODS
Animal Husbandry, Housing, and Surgery
Mouse-Osteotomy-Model
All animal experiments were approved by the local animal
protection authority (LaGeSo; permit numbers: G0039/16 and
G0111/13) following the German Animal Welfare Act.
Female C57BL/6N mice aged 10 weeks were ordered from
Charles River Laboratories (Sulzfeld, Germany) and underwent
surgery at the age of 12 weeks with an average body weight of
22 g. Housing took place in a conventional, semi-barrier (non-
SPF) facility and randomly split in groups with at least 2 mice
per cage housed in Eurostandard Type II clear-transparent plastic
cages with a wire lid and filter top. Fine wood chips (Lignocel
FS 14, J. Rettenmaier & Söhne GmbH + Co. KG, Germany) and
nesting material (Envirodri R©, Shepherd Specialty Papers, USA)
was provided. Houses and pipes were removed after surgery to
avoid injuries due to the external fixator. Food (Standard mouse
diet, Ssniff Spezialdiäten, Germany) and tap water was provided
ad libitum, and room temperature was between 20 and 22◦Cwith
a humidity of 45–50%. The light/dark cycle was a 12/12-h cycle.
Animals were tail and cup handled. Anesthesia was induced at
2.5% isoflurane (CP-Pharma, Germany) and maintained at 1.5%.
In order to cover pain after the surgery prior to surgery, all
animals received Buprenorphine (0.03mg/kg; Temgesic, Indivior
Eu Ltd., UK) s.c. as analgesic, an eye ointment and clindamycin
(0.02ml; Ratiopharm, Germany). After shaving and disinfecting
the left femur area animals were placed on a heating mat and
osteotomy was performed under aseptic conditions as described
earlier (21, 24). In short, the femur was prepared bluntly, after
a lateral longitudinal incision of the skin between hip and knee.
The external fixator (MouseExFix, RISystem, Switzerland) was
placed parallel to the femur by serial drilling of the pins (0.45mm
diameter). With a Gigli wire saw (RISystem, Davos, Switzerland),
a 0.70mm osteotomy gap was created in the middle of the femur
and flushed with NaCl. Following skin closure, mice received
pre-warmed NaCl (0.2ml) s.c., permeable wound dressing spray
and could recover from anesthesia in their home cage under
infrared light and close monitoring. Tramadol was applied via
the drinking water (0.1 mg/ml; Grünenthal, Germany) for 3
days after osteotomy (33). Given the short time period of
treatment, we expect no negative influence of the analgetics on
the fracture healing outcome (33). Surgery was performed by two
trained veterinarians. For general scoring and humane endpoints,
optimized protocols were used which has been summarized in
Lang et al. (34).
Combined Osteotomy and Intravital Imaging Model
All animal experiments were approved by the local animal
protection authority (LaGeSo; permit numbers: G0302/17)
following the German Animal Welfare Act.
Cx3cr1tm1Litt (CX3CR1:GFP), a fractalkine receptor
(CX3CR1) reporter mouse, and C57BL/6J animals were
bred in our colony. Heterozygous female mice were 14 weeks
of age when osteotomy was performed. Housing took place in
a conventional SPF barrier facility. Prior to surgery, all animals
received Buprenorphine (0.03 mg/kg; Temgesic, Indivior Eu
Ltd., UK) s.c. as analgesic and eye ointment. After shaving and
disinfecting the left femur area animals were placed on a heating
mat and osteotomy was performed under aseptic conditions.
Surgery was performed as previously described (10), using four
bi-cortical screws, and combined with osteotomy. In short,
the internal fixator’s Gradient Refractive INdex (GRIN) lens
tubing was modified to be screwed into the fixator plate after
implantation and osteotomy. Osteotomy was performed using
a 0.22mm Gigli wire saw (RISystem, Switzerland) and two cuts
for an osteotomy gap size of ∼816µm (CI: 787–844µm; SD =
85µm; n = 37). After removing the generated bone piece, the
lens tube was positioned into the osteotomy gap and screwed
into the fixator plate. Analgetics (Tramadol, Buprenorphine)
were applied as described above. For antibiotic treatment mice
received one injection of 0.04% Enrofloxacin (Baytril, 10 mg/kg
body weight Bayer AG, Germany) before surgery.
Bone Sample Preparation
Femoral bones were explanted, muscles largely removed in a way
that osteotomized bone parts maintained one entity. Tissue was
fixed using 4% electron microscopy-grade PFA in PBS for 4 h at
4◦C, washed in PBS, and ran through a sucrose gradient (10%,
20%, 30%; á 12–24 h). The fixators were removed from the fixed
samples, underwent µCT measurement, bones were frozen in
SCEM medium (Sectionlab, Japan), cut into slices of 7µm using
Kawamoto‘s film method (35), and stored at−80◦C.
Histology
Movat’s Pentachrome staining was conducted as descried
previously (21, 24). TRAP staining for quantification was
performed using a kit following the manufacturer’s instructions
(Thermo Scientific, 386A-1KT, MA, US). Individual slides
were stained using small volumes of staining solutions on
a heating plate at 37◦C. For immunofluorescence, individual
sections were thawed, rehydrated in PBS, blocked with 10%
donkey serum, and stained with antibodies in PBS/0.1%
Tween 20/5% donkey serum containing DAPI for 1–2 h. Target
Frontiers in Immunology | www.frontiersin.org 3 November 2019 | Volume 10 | Article 2588
Stefanowski et al. Macrophages and Vessels During Bone Healing
proteins were identified using antibodies against CD31/PECAM-
1 (goat polyclonal unconjugated, AF2628, R&D Systems, 1:100),
CD206/MMR (C068C2 conjugated to AF594, BLD-141726,
1:100), CD80 (goat polyclonal unconjugated, AF740-SP, 1:100),
Endomucin (Emcn) (V.7C7 unconjugated, sc-65495, 1:100),
F4/80 (Cl:A3-1 unconjugated, MCA497G, 1:400), GFP (goat
polyclonal conjugated to AF488, 600-101-215, 1:100), Ly-6C (ER-
MP20 biotinylated, MA5-16666, 1:20), Ly-6G (1A8 biotinylated,
BLD-127603, 1:200), Mac-2/Galectin-3 (M3/38 unconjugated,
BLD-125401, 1:100), Osx (rabbit polyclonal, sc-22536-R, 1:200),
Runx2 (EPR14334 conjugated AF647, ab215955, 1:100), Sox9
(EPR14335 unconjugated, ab185230, 1:200), VEGFA (rabbit
polyclonal unconjugated, ab46154, 1:100). Primary antibodies
were stained with secondary antibodies when unconjugated
(1:500, Thermo Fisher, anti-rat conjugated AF488, A21208;
anti-rat conjugated AF546, A11081; anti-rat conjugated AF594,
A21209; anti-rabbit conjugated AF488, A21206; anti-rabbit
conjugated AF546, A10040; anti-rabbit conjugated AF647,
A31573; anti-goat conjugated AF647, A21447; or streptavidin
conjugated AF546, S11225). Samples were washed between steps
and after staining with PBS/0.1 % Tween 20 for 3 × 5min.
Stained samples were kept in PBS for 5min and embedded using
aqueous mounting medium (Fluoromount, Thermo Fisher, MA,
US) and analyzed microscopically within 6 days. Simultaneous
detection of Ly6C and Ly6G was considered to indicate presence
of the Gr-1 protein.
Movat’s Pentachrome images were taken with a light
microscope in a 2.5×magnification and the programAxioVision
(both Carl Zeiss Microscopy GmbH, Germany). For Figure 2,
images (CD31 & Emcn) were taken with a Keyence microscope
(BZ 9000) using a 10x or 4x objective. All other images were
acquired at a Zeiss LSM880 in tile scan mode at a resolution of
2048 × 2048 using a 20x objective, unless specified otherwise.
For display, pictures were background subtracted and contrast
adjusted using ImageJ 1.52i.
Image Analysis
Image analysis of cell and tissue distribution (Figure 2) was
performed with ImageJ and an own developed pipeline which
has been published and described in detail previously (21). Mean
intensity was determined with ImageJ within the marked ROIs
distinguishing between the gap, the adjacent to the gap and
the bone marrow area. Mean intensities were normalized to the
maximum intensity of the image.
Quantification was performed in CellProfiler 3.1.8.
(36) (Supplementary Figure 1). Macrophage subsets were
described via the co-localization of identified CX3CR1+,
Gr-1+, and F4/80+ objects. CX3CR1+F4/80+Gr1+ objects,
representing cells were divided by roundness based on object
shape features (FormFactor, Perimeter, Min Feret Diameter,
Supplementary Figure 5). Objects were only considered cells
when they overlapped with a nucleus (DAPI) signal. In a
second pipeline localization of F4/80+ macrophages towards
the Emcn+ endothelium was analyzed by examination of the
direct (≤3.5µm) and distant (>7µm) neighborhood of the
subset. Localization of the identified subsets was analyzed
by counting the identified objects in regions of interests
(ROIs). ROIs for the osteotomy gap were determined as
shown in Figure 5E. For neighborhood analysis and frequency
determination (Figures 3E,F) either Emcnhi or Emcnlo areas
within the osteotomy gap or distant thereof were encircled
freehand using ImageJ 1.52i, respectively (Figure 3D). Areas
close to Sox9+ chondrocytes were excluded as they did contain
few, if any macrophages. Emcnhi areas largely overlapped with
F4/80hi areas.
Object Identification and Neighborhood Analysis
For the segmentation, the model-based approach was applied
(37). Otsu was used as a segmentation algorithm calculating the
thresholds for the object edge identification. Mid-level pixels
were assigned to the background. The threshold calculation was
performed adaptively, which allows adaptation of the threshold
to different image sub-regions. For each channel, the parameters
were manually optimized by visually inspecting the segmentation
results. To aid the segmentation, channel specific object ranges
were estimated (e.g., nuclei = 3.1–12.5µm). Clumped cells
were separated based on their intensity distribution. Only partly
visible cells touching the border of the image were removed
from the segmentation process. Nuclei, CX3CR1, F4/80, and
Emcn primary objects were identified based exclusively on the
image. Due to the dense packing of Gr-1+ cells, segmentation
was performed via secondary object identification with prior
segmented nuclei as cellular reference. The segmentation was
channel dependently refined based on various object features
(Supplementary Figure 1B). Objects features were extracted on
the boundaries of the objects for shape (e.g., perimeter, area,
radius; Supplementary Figure 5), and intensity, computed from
the signal intensity values of the object area within a defined
image channel. Filter and thresholds were determined by visual
evaluation of specific phenotypic measurements of individual
objects within the image and the global distribution of the
phenotypic measurement within the whole image.
Spatial Polarization Scoring
Bone orientation was determined using Movat’s Pentachrome
overview images. Scores were determined for individual channels
(DAPI, F4/80, or CD31). Scores were determined considering
the staining intensity and abundance of the signal in parts
of the bone marrow not affected by the injury (homeostatic
control), on the same slide in at least 400µm distance from
the injury site. Scores were: −2 for the absence of staining in
the area or reduced signal abundance and intensity throughout
the entire area.; −1 for signal either reduced in intensity
but displaying comparable abundance, or reduced abundance
and comparable intensity; 0 for appearance that resembles
homeostasis (unaffected bone marrow in the same section);
1 for higher intensity at comparable or increased abundance
that localized only partially along the line between the gap
and the adjacent tissue. Adjacent tissue is tissue along the
contour between bone marrow and hematoma, bone fragments,
and callus; 2 for higher intensity at comparable or increased
abundance along the entire length of the line between the gap
and the adjacent tissue or in large areas extending >400µm
distance from the gap in the bone marrow tissue. Regions often
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showed enlarged and unstructured vessel organization, with
very bright F4/80 cells between the endothelial lines. Samples
were considered spatially polarized when the scored values for
F4/80 and vessel marker of proximal and distal to the fracture
gap resulted in a difference >2 favoring one side (proximal,
distal). Samples which scored a difference of <2 were considered
neutral. In total n = 20 samples were analyzed, 9 samples
scored values other than 0 of which 2 samples were considered
neutral, 1 polarized proximally and 6 polarized distally
(Supplementary Figure 4A).
Longitudinal Intravital Microendoscopy of
Murine Osteotomy
As a GRIN lens system, we used custom singlet GRIN needle
microendoscope (length ca. 5.07mm, diameter = 0.60mm;
NEM-060-10-10-850-S-1.0p, GRINTECH Jena, Germany). The
GRIN lens was glued into the lens tubing to a final
penetration depth of 650µm when screwed into the fixator
plate. CX3CR1:GFP mice were anesthetized and mounted to the
microscope as previously described (10). Qtracker 655 Vascular
Label (Thermo Fisher, MA, US) were injected and images
were acquired (505 × 505 px, 500 × 500µm, unidirectional,
line average 4, step size 4.5–6.5µm, ca. 18 steps, stack time
60 sec). Image stacks were loaded into Imaris 9.3.0 software
(Bitplane Zürich, Switzerland), median filter (3 × 3 × 3)
was applied. Videos were exported (1024 × 1024, 4 fps) and
images were angled maximum intensity projections. Individual
mice were measured at 940–950 nm on day 2, 3, 4, 5
after osteotomy.
Statistical Analysis
Statistical analysis was carried out with GraphPad Prism V.5
or V.8 software. All values are expressed as the mean ±
SD if not stated otherwise. Mann-Whitney U-test, Wilcoxon-
signed rank test and Friedman test with Dunn’s post-hoc
test were mainly used, since Gaussian distribution was not
expected due to inter-individual variations. A p < 0.05 was
considered statistically significant. Image analysis was blinded for
time points.
RESULTS
EmcnhiCD31hi Endothelium Is Present
During Endochondral Bone Formation in
the Osteotomy Gap
Fracture healing consists of consecutive phases. Progression into
each phase depends on the undisturbed and error-free course
of the respective previous phase (38). In the mouse-osteotomy
model used in this study, residuals of cells in the fracture
hematoma are visible in Movat’s Pentachrome staining at day 3,
while the osteotomy gap is filled with a mixture of bone marrow
cells including hematopoietic cells at day 7, and endochondral
bone formation occurs between day 14 and day 21 (Figure 1A).
Using immunofluorescence histology, a positive signal for CD31
(Platelet endothelial cell adhesionmolecule 1) is seen in elongated
cells inside the fracture hematoma, which include no detectable
nuclei (Supplementary Figures 2A–C), probably indicating that
these residuals represent endothelial cells that may have lost their
integrity. In order to further characterize the cellular composition
within the fracture area, immunofluorescence staining for
key transcription factors of mesenchymal differentiation was
performed on serial sections of the same bones (Figure 1B).
Already at day 3, osteoblast progenitors characterized by nuclear
expression of Runt-related transcription factor 2 (Runx2) are
dispersed in the fracture gap. By day 7, their number has
increased, leading to a dense population of the gap, whilst
sparing a region in the center. The peripheral borders of the
gap and adjacent periosteal regions are populated by cells co-
expressing Runx2 and SRY-box transcription factor 9 (Sox9) in
the nucleus, indicating their potential for either osteogenic or
chondrogenic differentiation (Figure 1B). This is in accordance
with the blue-greenish color in corresponding regions of Movat’s
Pentachrome staining, indicative of cartilaginous tissue (Alcian
blue positive). At day 14, Runx2+ cells are found to localize on
both sides of the gap. Single Runx2+ cells are surrounded by areas
characterized by the presence of only a few nuclei, in line with
the presence of mineralized bone in those areas, as visualized by
Movat’s Pentachrome staining (compare: Figures 1A,B). Sox9+
cells are exclusively present in the center of the gap at this time
point. Notably, the majority of these cells do not co-express
Runx2. In contrast, at day 21, a time point when mineralization
of the gap is complete, the progenitors identified in this area
are almost exclusively Runx2+. In a next step, Osterix (Osx)
and CD31 stainings were performed on serial slides from the
same individuals. Direct comparison reveals that at day 3, only
some Runx2+ cells are also Osx+, indicating various degrees
of osteogenic differentiation. From day 7 on, Runx2+ cells are
also positive for Osx+, consistent with ongoing maturation
of osteoblasts. Osx+ osteoblasts localize in the fracture gap
alongside existing and newly formed bone, as indicated by
differential interference contrast (DIC) signal. Sox9+ cells can
be found at day 14 and 21 in areas with cartilage and close
to Osx+ cells, indicating ongoing further differentiation and
mineralization, which is accompanied by vascularization. For
further quantitative analysis of the vasculature sprouting into
the gap, we defined the gap as a rectangular region between the
cortical ends and analyzed CD31+ vessels and Osx+ bone cells
in this region (Figure 1C). At day 3, CD31+ matrix (residuals
of the fracture hematoma) and some CD31+ cells are present
(compare to Supplementary Figures 2A–C), while Osx+ cells
enter the osteotomy gap at later time points, between day 7–21
(Figures 1C,E). At later phases of fracture healing, endothelial
cells displaying the phenotype of type H vessels (EmcnhiCD31hi)
closely associate with Osx+ osteoprogenitors/pre-osteoblasts
(Figure 1C). Investigating the co-localization of Runx2+ and
Sox9+ cells with respect to CD31+ endothelium reveals a close
localization of Runx2+ cells around vascularized areas, while
Sox9+ cells are only found in less vascularized areas (Figure 1D).
Our results confirm a close relationship between vessel formation
and osteoprogenitors/osteoblasts and extend previous reports of
this phenomenon, which focused on bone development (7), to a
regenerative scenario.
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FIGURE 1 | Histological characterization of tissue formation and distribution of mesenchymal progenitor cells, osteoblasts and endothelial cells during bone
regeneration in a mouse-osteotomy model. (A) Movat’s Pentachrome staining indicates the phases of bone regeneration over 21 days. Scale bars = 500µm. (B)
Sox9 and Runx2 immunofluorescence staining for progenitor cells undergoing differentiation at day 3, 7, 14, and 21 indicating double-positive cells at day 7 and high
numbers of Runx2+ cells within the fracture gap at day 14 and 21. Exemplary images of n = 3–6 per time point. Scale bars = 200µm. Insets show enlarged
(Continued)
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FIGURE 1 | representative areas marked by white frames. (C) Exemplary images at day 3, 7, 14, and 21 displaying the distribution of CD31+ ECs and Osx+
osteoprogenitors/pre-osteoblasts revealing close proximity between CD31+ endothelium and Osx+ cells. Scale bars = 200µm. (D) Exemplary images for Sox9 or
Runx2 and CD31 staining at day 7. Insets show enlarged representative areas marked by white frames. While Runx2+ cells can be found closed to endothelial cells,
Sox9+ cells can be found in not yet vascularized areas. (E) Quantification of cellular compartments present in the fracture gap during regeneration. Endothelial cells
(ECs; CD31+) and osteoprogenitors/pre-osteoblasts (Osx+) were quantified based on the relative presence of positive pixels with the respective markers in
immunofluorescence images supporting the descriptive analysis on the spatiotemporal distribution of progenitor cells, osteoblasts and endothelial cells over time.
Data show mean ± SD for n = 3–6.
Localization and Morphologic
Characterization of EmcnhiCD31hi Type H
Endothelium
While EmcnhiCD31hi endothelium can be found directly in
the osteotomy gap and in the adjacent tissue, EmcnloCD31lo
endothelium is prominent in bone marrow regions not affected
by the injury. Pixel intensity analysis confirms the differences
between the Emcn+ and/or CD31+ cells in and adjacent to the
osteotomy gap, compared to the bone marrow (Figures 2A,B).
We further characterized the type H vessels in the fracture gap
(Figures 2C,D). During vascularization of cartilaginous tissue,
invading vessel buds (distal loops), previously described as a
morphological criterion for type H endothelium (7), can be
identified (Figure 2E, first row marked by arrows). Furthermore,
CD31+ arterioles, which are negative for Emcn, are found within
the osteotomy gap. However, a second morphological criterion
described to be typical for type H vessels in the growth plate
areas, namely their columnar structure, does not appear during
regeneration, suggesting that this ordered arrangement is a
specific feature of bones undergoing longitudinal growth. Taken
together, our data reveal the appearance of EmcnhiCD31hi in
the fracture gap, which share additional distinct morphological
features with the previously described type H vessels, although
they are not organized in columnar structures. This finding
suggests an important role of this osteogenic vessel type not only




In order to determine the role of macrophages in the context
of vascularization during bone regeneration, we analyzed
macrophage subsets and their spatial localization relative to
type H vessels. Based on the pan-macrophage marker F4/80,
which includes also osteomacs, we defined M1- and M2-
like macrophages labeled by CD80 and CD206 (Mannose
receptor), respectively, as well as Mac-2 (Galectin-3), a marker
associated with pro-inflammatory macrophages (22). Over the
course of endochondral bone regeneration, F4/80+ cells localize
throughout the bone marrow, as well as on the border to
bone surfaces, accumulating in various areas (Figure 3A). At
day 3 post-osteotomy, high numbers of F4/80hi cells localize in
periosteal regions adjacent to the osteotomy gap. They can be
found periosteal in varying numbers throughout the regeneration
process, until the bone remodeling phase at day 21. At day 14,
F4/80hi cells are found exclusively in periosteal regions, whereas
they are found in both the medulla and the periost at day 21.
Extra-medullar F4/80+ macrophages are positive for the anti-
inflammatory M2(a) macrophage marker CD206 (Figure 3A,
blue framed inset). Those M2-like cells are not abundant in the
marrow or at sites of vascularization, where expression of CD206
is generally lower and macrophage morphology rather ramified
(Figure 3A, yellow and orange framed insets). CD206 expression
is also found in cells resembling the morphology of endothelia
(Emcn+), which are F4/80− throughout the regeneration
process as well as under homeostatic conditions (Figure 3A,
yellow framed inset; Supplementary Figures 3C,D). M1-like
macrophages, defined by expression of CD80, are extremely rare
and only few are found at day 3, with their abundance comparable
to control tissue (Supplementary Figures 3B,D). Using the
marker Mac-2 in addition, almost all CD206+ macrophages are
found to be positive for Mac-2 at day 3, however, not all Mac-
2+ cells are CD206+ (Figure 3B). Mac-2 positive cells localize
in the fracture gap and in proximity to the bone surfaces. Over
the course of regeneration, double-positive Mac-2+ and CD206+
cells vanish and cells which are single positive for each of the two
markers are detected at day 21, a time point when remodeling
is ongoing (Figure 3B). Quantitative pixel-based area analysis of
F4/80 macrophages, CD31 and TRAP shows that CD31+ and
F4/80+ cells are reduced over time, while the number of TRAP+
cells (osteoclasts or activatedmacrophages) increases (Figure 3C;
Supplementary Figure 3A).
CD206+ macrophages are present throughout the healing
process with no apparent preferential localization towards the
vasculature, and they are mainly Mac-2+ in the early phase of
regeneration. Over the course of regeneration, F4/80-expression
decreases in regions adjacent to the callus, and at later time
points only few areas, which contain cells expressing F4/80 at
intermediate levels, are observed.
F4/80+ and CD80+ Cells Produce VEGFA
During Early Regeneration and
Osteoblasts and Chondrocytes Are the
Main Producers at Later Time Points
Since we could not find substantial amounts of CD80+ cells
at day 3 post-osteotomy, we analyzed the regeneration at day
1 and day 2. Some CD80+ cells were found at day 1, and
they were abundant in higher numbers at day 2 post-osteotomy
(Figure 4A). Some of those are F4/80+CD80+ macrophages,
which localize in areas adjacent to the osteotomy gap. CD80+
cells are located directly at the injury site (Figure 4A, day 2).
Macrophages are known to support vascularization via VEGFA
during tissue regeneration, which is why next, we analyzed
VEGFA using immunofluorescence histology over the time
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FIGURE 2 | Vessels formed during fracture healing show characteristics of type H endothelium and are embedded in mineralized tissue. (A) Intensity analysis of Emcn
and/or CD31 in the fracture gap. Mean intensities were normalized to the maximum intensity present in each image. Mean intensities were normalized to 780 the
maximum intensity present in each image. Data are shown as scatter dot plot with mean ± SD while one dot is representative for one slide of one individual animal.
(Continued)
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FIGURE 2 | Friedman test with Dunn’s post-hoc test were performed to determine statistical differences; p-values are indicated with *p < 0.05, **p < 0.01. (B)
Emcnhi CD31hi endothelium shows spatial differences in abundance throughout the bone. Exemplary image showing the definition for the osteotomy gap, the gap
adjacent regions and the bone marrow area, as used in our analyses. Scale bar = 200µm. (C) Images of Emcnhi CD31hi endothelium at day 3, 7, 14, and 21. Data
are representative for n = 3 (d3/7) and n = 6 (d14/21). (D) Quantification of areas occupied by Emcnhi CD31hi type H endothelium during the time course of bone
healing. Data are shown as Mean ± SD. (E) Emcn and CD31 staining combined with phase contrast images (DIC) in the soft to hard callus transition of fracture
healing highlight morphological characteristics also present in growth plate bone growth. Upper panels: invasion of vessels in cartilaginous tissue and type H
vessel-like budding is indicated by arrows. Lower panels: CD31+ only vessels are assumed to be arterioles (arrows) (7). Scale bars = 200µm.
course of bone regeneration (Figures 4B–D). VEGFA is not
expressed by F4/80+CD80− macrophages throughout the entire
process, but CD80+F4/80− and a fraction of CD80+F4/80+ cells
express VEGFA. This expression was restricted to very early time
points, namely day 1 and day 2 (Figures 4B,C). From day 3 on,
VEGFA is found to be expressed in the fracture gap and along
bone surfaces (endosteal, periosteal) and in the bone forming
areas (Figure 4D). The signal for VEGFA at day 14 is pronounced
in areas, which also contain Sox9+ and Runx2+ cells (Figures 1B,
4D). Taken together, VEGFA expression is observed in CD80+
cells, including a fraction of F4/80+ cells, in the early phase
until day 3, after that, VEGFA is expressed predominantly by
osteoblasts and chondrocytes in bone forming areas.
Cells Within the Osteotomy Gap Localize in
Proximity to the Endothelium
High abundance and expression of the vascular markers CD31
and Emcn is observed in both, the damaged tissue in the early
regeneration, and in bone forming tissue over the subsequent
course of regeneration in the osteotomy gap (Figure 2C). These
areas rich in type H vessels, simultaneously contain F4/80hi cells
(Figures 3A,D). In order to evaluate the proximity in localization
between macrophages and type H endothelium, we defined two
regions for each sample, the Emcnhi region and the Emcnlo
region (Figure 3E). Objects in these regions were segmented
based on marker expression of Emcn, F4/80 and DAPI. Over
the course of regeneration, similar frequencies of 25.0 ± 11.6
% F4/80+ cells are present in both, the Emcnhi and Emcnlo
regions. The frequencies of F4/80+ cells decrease significantly
from day 3 until day 21 post-injury (Figure 3E), confirming
the qualitative results from Figure 3C. Next, we analyzed the
position of macrophages relative to the endothelium, and found
that, a two- to three-fold higher number of objects (F4/80+
objects or identified nuclei, which serve as a control for all cells)
localize in proximity to the endothelium in the Emcnhi region
as compared to the Emcnlo region (Figure 3F). Cells are defined
as “in proximity” when they are located less than half a nuclear
diameter in distance (<3.5 um) away from the endothelium.
During analysis of immunofluorescence staining in samples
of osteotomized, LIMB-implanted bones, we noticed a
transient, strongly polarized distribution of newly formed
vessels to the distal area of the osteotomy gap (Figure 5A;
Supplementary Figure 4A). A similar polarization occurs in
samples of the osteotomy-model (Supplementary Figure 4B).
In some cases, this phenomenon is accompanied by a variation
in cell density in the respective area, as shown by differences
in the abundance of the DAPI signal. Scoring according to the
criteria described in the methods section for the abundance and
intensity of the markers in the gap-adjacent regions reveals that
CD31+ vessels are significantly brighter and more abundant
adjacent distally to the gap, as compared to the proximal site
(Figure 5B). This spatial polarization with respect to bright
CD31+ vessels is pronounced at day 4 and decreases quickly
afterwards (Figure 5B). A similar trend is observed for F4/80+
cells in the same regions (Figure 5B). Taken together, these
analyses reveal a transient, directional spatial polarization
(regarding the localization from the fracture gap) of CD31hi
vessels, adjacent to the fracture gap.
CX3CR1+ F4/80+ Macrophages Precede
Vascularization
In order to understand the dynamics of macrophages during
bone regeneration, we took advantage of the fractalkine receptor
(CX3CR1) reporter mouse strain CX3CR1:GFP. These mice
were implanted with a Gradient Refractive INdex (GRIN) lens,
enabling longitudinal imaging of the bone marrow during
regeneration (10). At the same time, these mice underwent
osteotomy surgery. Since the first wave of vascularization
occurs during resolution of the fracture hematoma, bones that
had been treated using the procedure described were fixed
and analyzed at day 4, 6, and 8 using immunofluorescence
histology. In order to be able to exclude monocytes and
granulocytes from the macrophage analysis, we stained sections
using antibodies against Ly-6C/Ly-6G (Gr-1). We find that
almost all F4/80+ macrophages in the osteotomy gap are also
CX3CR1+ (Figures 5C,D, yellow), confirming that the reporter
mice are suitable for tracking macrophage dynamics during bone
regeneration. GFP+ cells are present within the osteotomy gap
at early time points and become less abundant over time. They
locate in close proximity to CD31hi endothelium, do not express
Gr-1 (Figure 5D), excluding the possibility that some of them
are granulocytes, which are also described to be CX3CR1+. We
analyzed the osteotomy gap between the cortices and the bone
marrow as described in Figure 5E. At day 6, of all identified cells
in the osteotomy gap, the CX3CR1+ cells display the highest
increase in cell number, as compared to homeostasis. A minor
increase is detected in F4/80+ cells and a strong reduction of
Gr-1+ cells is observed compared to homeostasis (Figure 5F).
The space is largely occupied by F4/80+ myeloid cells, which are
not monocytes (Gr-1−). The strongest increase in cell number
is observed in the CX3CR1+Gr-1-F4/80+ subset, which make
up to 12% in ratio to all nuclei at day 6 (Figure 5G). Almost
6% of CX3CR1+ objects are F4/80− and only few are Gr-
1+. Morphologically, the cell phenotype is of non-round shape
(Figure 5E, Supplementary Figure 5). We then longitudinally
sampled time-lapse videos with two-photon microscopy from
individual mice over the course of the early regeneration process.
On the first and second day, almost no signal is detected inside
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FIGURE 3 | Distinct localization of macrophage subsets during bone regeneration indicates location-dependence of their functions. (A) Immunofluorescence staining
of F4/80, CD206, and Emcn shows the abundance of F4/80+ cells in the osteotomy gap. They localize close to Emcnhi endothelium. F4/80+CD206+ M2-like
macrophages primarily localize in extramedullar areas (blue inset). F4/80hi cells localize in proximity to Emcnhi endothelium (yellow inset). Endothelium shows
CD206-positivity in proximity to the gap (orange inset). Scale bars = 500µm. (B) Immunofluorescence staining reveals spatiotemporal distribution of CD206+ and
Mac-2+ cells. CD206+ M2-like macrophages were Mac-2+ at d3 and single-positive by d21. Scale bars = 500µm. (C) Pixel-based area analysis of
immunofluorescence images of CD31, F4/80, and TRAP show a reduction of CD31 and F4/80 signals over time and an increase in osteoclasts. (D) Object-based
analysis for (E,F), based on regions within the osteotomy gap which show high or low expression of Emcn (Emcnhi vs. Emcnlo ). Scale bar = 500µm. (E) F4/80+ cell
frequency in the Emcnhi region decreases between d3 and d21 to levels of the Emcnlo region. Mann Whitney test, two-tailed, *p = 0.0476. (F) Proximity analysis
(Continued)
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FIGURE 3 | performed by object-based quantification in two distances from the endothelium. Data was normalized to the overall number of the object population in
the respective region. Compared to the Emcnlo region, more objects (F4/80+ or nuclei) localize in proximity to the endothelium in the Emcnhi region. Cells were
considered in proximity to each other when their distance amounted to that equivalent to less than half of a nucleus diameter (<3.5µm), in order to include cells which
are either in contact with or in the direct vicinity of vessels. Cells were considered distant were located further than one cell layer (>7µm) apart from each other. Data
are representative for n = 3 (d3/7) and n = 6 (d14/21).
the osteotomy gap (data not shown). On day 3, individual
CX3CR1+ cells enter the hematoma (Figure 5Hd3). Those cells
display a non-round, but non-ramified shape and move through
the tissue (Supplementary Movie 1). A front of CX3CR1+ cells
forms at the edge of the field of view at day 4, containing
both round and non-round cellular phenotypes, forming a
dense, partially resident population which expands into the
entire field of view (Figure 5H, Supplementary Movies 2, 3).
This invasion is accompanied by the occurrence of perfused
vessels that expand, following the CX3CR1+ cell front until
the field of view appears vascularized (Supplementary Movie 4).
Under full vascularization, sessile CX3CR1+ cells localize
towards the vasculature and motile cells can be observed
to move along the endothelium (Supplementary Movie 3).
Generally, the abundance of CX3CR1+ in the gap increases
with progression of the regeneration process (Figure 5F,
Supplementary Movies 3, 4).
These results indicate that most cells in the fracture
gap are myeloid, non-monocytic, non-granulocytic, non-round
CX3CR1+ which invade the osteotomy hematoma starting day
2–3, become gradually sessile in the fracture gap at day 3–
4, where they precede the vasculature until it becomes fully
perfused. After vascularization, CX3CR1+F4/80+ cells persist
until the onset of the remodeling phase.
DISCUSSION
Vascularization is pivotal to the success of complete, scar-
free bone regeneration. Here, we show that after bone injury,
type H endothelium evolves in the bone formation region
and persists throughout the entire bone regeneration process.
Our findings show that the phenotype of type H endothelial
cell structures described in endochondral long bone growth, is
also reflected in bone regeneration. EmcnhiCD31hi endothelium
shows association with Osx+ osteoblasts and displays typical
features that can be observed in the growth plate during
longitudinal growth, such as invading vessel buds and arch-like
structures described before (7). Other than their counterparts in
the growth plate, type H vessels generated during regeneration
are not columnar. However, this feature is probably not inherent
to type H vessels, but merely the result of the highly ordered
structure of chondrocytes in the metaphyseal areas. These
chondrocytes are organized into columns that are produced in
the growth plate, and probably impose their structure on the
type H vessels in these areas. In contrast, the tissue structure
surrounding type H vessels in a fracture gap appears more
disorganized. We have previously shown that the amount of type
H vessels can be used as ameasure of fracture healing progression
(21). Ramasamy et al. reported the effect of shear stress in
the vascular formation during bone development, therefore
it would be interesting to analyze whether interfragmentary,
compressional mechanical cues also act on the formation and
structure of type H vessels in fracture healing (39).
We found an extensive staining of CD31 in the gap, which
dominates the initial hematoma phase (until day 3–4). This
staining seems not to be associated with intact cells, since no
nuclei are present. It is possible that CD31+ cells are present in
the early fracture hematoma during the first hours after injury
and undergo cell death due the hypoxic microenvironment,
including a low pH and high lactate level in the tissue, and that
the staining pattern observed represents dead endothelial cells.
Based on our results, and similar to a previously reported
model in sheep (6), we propose that two phases of vascularization
occur during bone regeneration also in mice. The first wave
of vascularization occurs during disintegration of the fracture
hematoma, where vascular sprouts from existing endothelial cells
enter into a hypoxic environment. It occurs between the initial
injury and day 6, until the entire volume is fully vascularized
for soft callus formation. We observe this phase histologically
and by intravital microscopy. After the first wave, and once the
callus becomes calcified, we assume that the vascular network
within hard callus and bone is remodeled in a second phase,
based on the changes that happen during tissue reorganization.
It has been described that most of the progenitor cells that
contribute to fracture repair immigrate from the periosteum
(40). In addition, these progenitor cells either express Sox9
or Runx2, which are regulated by direct repression of the
opposing pathway (via β-catenin expression) and define further
differentiation into chondrocytes or osteoblasts, respectively
(41). However, several studies show the importance of Sox9
expressing progenitor cells that support mineralization and
osteogenesis within the fracture gap (42–44). At day 7, we
observe a co-localization of Sox9 and Runx2 (Figure 1B), it can
be speculated that co-expression of both transcription factors
marks a switch in the genetic program, from uncommitted
pre-osteoblasts to chondrocyte differentiation, similar to what
has been shown in bone development (45). Alternatively, Sox9
expressing cells might differentiate into osteoblasts, as described
previously (42–44). Our results show close proximity between
osteoprogenitors (Runx2+) or osteoblasts (Osx+) and CD31+
endothelium (Figures 1C,D). Endothelial cells, which display the
phenotype of type H vessels (EmcnhiCD31hi) closely associate
with Osx+ cells in this osteotomy (= cortical defect) model. Type
H endothelia have been previously described to be present in the
metaphyseal areas of young animals, where they promote bone
growth (7). The results presented here indicate a similar crosstalk
to occur in endochondral osteogenesis during regeneration.
The large extent of angiogenesis, which occurs in the fracture
gap, raises the question for factors and cell types which trigger
this event. In the growth plate, hypertrophic chondrocytes
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FIGURE 4 | Expression of VEGFA in CD80+ cells and bone forming areas at the osteotomy site. Immunofluorescence staining over the course of regeneration shows
(A) pro-inflammatory CD80+ cells adjacent to the osteotomy gap, which are in part F4/80+ in the early phase (at day 1 and 2). (B) F4/80+ cells were predominantly
VEGFA−. (C) CD80+VEGFA+ cells localize at the interface between the hematoma and surrounding tissue. (D) In areas of bone formation VEGFA expression is high,
but F4/80+ cells re VEGFA− during progressing bone regeneration until day 21. Scale bars = 500µm. n(day 1) = 3, n(day 2) = 1.
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FIGURE 5 | Quantitative analysis and LIMB imaging demonstrate high abundance of the myeloid CX3CR1+ F4/80+ cell subset preceding vascularization. (A)
Overview image of a section from a whole bone taken at day 4 after LIMB osteotomy. The LIMB osteotomy-model model uses a gradient refractive index lens which is
removed before bone sectioning thus a lens void remains. Vessels and macrophages polarize distally in this example. (B) Scoring of CD31 and F4/80 allows
(Continued)
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FIGURE 5 | quantification of polarization in proximal or distal orientation with respect to the fracture gap. Scoring of DAPI staining was used as internal control.
Wilcoxon matched-pairs signed rank test. Data are representative for n = 7 (d4), n = 6 (d6), n = 4 (d8), and n = 3 (d14). (C) Immunofluorescence images of sections
from bones showing the presence of myeloid subsets at various time points after LIMB osteotomy. CX3CR1:GFP+ and F4/80+ cells negative for Ly6C/Ly6G (Gr-1),
accumulate at and invade into the fracture gap. Scale bars = 200µm. (D) Inset of the area of d8. The majority of myeloid cells are CX3CR1+F4/80+ and localize in
distance from Gr-1+ cells. Scale bars = 200µm. (E) Quantitative analysis is performed in the rectangular region of the fracture gap between corticalis, osteotomy cuts,
and lens void (osteotomy gap). Scale bar = 100µm. (F) Quantitative, object-based analysis of the osteotomy gap for Gr-1, F4/80, CX3CR1:GFP show a decrease of
Gr-1+, an increase of F4/80+ and massive increase of CX3CR1+ cells. Results of 20 pooled samples. (G) Object-analysis among the CX3CR1+ cells reveals that
Gr-1−F4/80+ account for the majority of cells present in the gap over the whole time course of regeneration (left panel). Of those, the majority were non-round cells
(right panel). (H) Intravital two-photon LIMB-microscopy of the osteotomy gap in an individual CX3CR1:GFP mouse. CX3CR1:GFP+ cells invade the osteotomy gap in
the displayed field of view (250 × 250µm) at day 2–3 and fully populate the region by day 3–4. Simultaneously, numerous CX3CR1+ cells precede the vascularization
in space and time. Vasculature was made visible using intravenous injection of Qtracker 655. Scale bars = 100µm. Data are representative of 5 mice analyzed.
produce high amounts of VEGFA, due to the hypoxic
microenvironment in those areas, in which HIF stimulates
VEGFA expression (7). In a recent publication, Buettmann et al.
deleted VEGFA from early osteolineage (Osx+) cells, mature
osteoblasts and osteocytes (Dmp1+) as well as ubiquitously in
models of cortical fractures (full and stress fractures) and a
cortical defect model (drilling). Bone regeneration and periosteal
angiogenesis after a cortical defect was impaired only when
VEGFA was deleted either ubiquitously or from Osx+ cells,
indicating a predominant role of osteolineage cells. After drill
hole injury, however, the deletion did not lead to delayed healing,
indicating that another cell type than Osx+ is responsible for
VEGFA production and the progression of vascularization.
Macrophages have been identified to play a role in bone
regeneration, as their deletion either via clodronate (24, 25) or
genetically delays healing. Data available in the literature indicate
multiple functions for macrophages during bone regeneration.
Recently, the supportive function of F4/80+ macrophages during
bone regeneration via enhanced osteogenesis when transplanted
to aged individuals was demonstrated (46). In addition, it is
known that F4/80+ osteomacs support osteoblast function (47).
Osteoblast differentiation and mineralization have also been
shown to be modulated by macrophages (48, 49). However,
the role of macrophages in the vascularization of the fracture
is largely unknown. Here, for the first time, we quantitatively
and qualitatively map out the vascular network, relate it to the
presence of macrophages at relevant time points during bone
regeneration in mice and analyze presence and proximity with
different approaches. We find that F4/80+ macrophages and type
H endothelium localize at the front of damaged tissue in the first
phase until soft callus formation, when their presence is reduced.
In detail, our proximity analysis reveals that all cells, including
F4/80+ macrophages in the regenerating tissue, localize much
closer to the endothelium than in unaffected areas in both, the
first (d3–d7 after injury) and second (d14–d21 after injury) phase
of revascularization. We find CX3CR1+F4/80+ macrophages to
be a predominant subset in this process. Phenotypically, these
cells are for the most part non-round and ramified. They localize
predominantly in a one-cell layer around the endothelium.
Future work is needed to study the fate of this subset. It is
possible that those cells differentiate or merge with osteoclasts
and therefore promote remodeling of the bone.
Using longitudinal intravital microendoscopy of the
osteotomized region, we find that CX3CR1+ macrophages
precede the occurrence of perfused vessels into the hematoma
in the first phase and remain associated to the endothelium.
We show the type H endothelium to be closely associated with
CX3CR1+F4/80+ macrophages, suggesting that this myeloid
population is responsible for vascularization and progression of
bone regeneration.
In the fracture hematoma, no chondrocytes are present, so
macrophages may be a source of VEGFA in that situation. Here,
we identify two major cell populations, which produce VEGFA
over the course of regeneration. In the earliest phase, at day 1 and
2 post injury, CD80+ cells are found to be positive for VEFGA
by immunofluorescence. From day 3 on, cells inside the area
of bone formation and on bone surfaces show a strong VEGFA
signal. Based on their localization, the proximity to bone surfaces,
we assume that these cells are precursors of, and committed
osteoblasts, as well as chondrocytes in cartilage (16; compare
Figures 1A–C). Until day 3, among the CD80+ cells, we find
F4/80+, which we considerM1-like cells, as well as F4/80−, which
could either be a subpopulation of mature F4/80− macrophages
or precursors of macrophages, such as F4/80low monocytes (50).
In addition, other antigen-presenting cells such as B cells and
dendritic cells can be CD80+ (51, 52). It has been previously
described that VEGFA-expression of macrophages depends on
the stimulation state (53, 54). Additionally, tissue resident F4/80+
macrophages are not known to express VEGFA constantly, but
rather they interact with VEGFA-producing cells on promoting
vascularization and supporting sprout fusion (29, 55). Our results
support previous literature by showing VEGFA-expression
from immune cells (56). Here, CD80+ cells were expressing
VEGFA in the early phase until day 3, while the majority was
F4/80−. CD80+ M1-like macrophages have not been reported
to express VEGFA. It can be speculated from our data that
CD80+ cells contribute to the presence of VEGFA within
the fracture gap until bone cells differentiate and become the
dominant producers of VEGFA during the bone formation and
remodeling phase.
The presence of M1-like macrophages until day 3, the
subsequent decrease, and the absence at later time points in our
study indicates that the transition from the pro-inflammatory
phase to the anti-inflammatory phase in the myeloid
compartment has already taken place at day 3 in the osteotomy
models analyzed here. It has been described that a switch from
M1-like macrophages to an M2-like phenotype is essential for
successful healing. Under chronic inflammatory conditions
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it is impaired and accompanied by the prolonged presence
of M1-like macrophages (57). Consequently, recent research
focuses on this switch to improve healing (58, 59). Interestingly,
M1- and M2-like macrophages do not localize inside the
fracture gap, and rather CX3CR1+F4/80+ cells participate in the
initial and crucial vascularization process. Our spatial analyses
reveal that CD206+ macrophages localize in extramedullary
areas and, moreover, that they remain positive for the pro-
inflammatory maker Mac-2 until d14. After that, cells that are
positive for either CD206 or Mac-2 remain present until the
remodeling phase. The extramedullary localization of CD206+
macrophages may indicate that M2-like macrophages serve
functions beyond bone regeneration, for example skeletal muscle
regeneration (60).
Of note, during the regeneration process, the
immunofluorescence signal for Emcn+ in the endothelium
partially co-localizes with the signal for the mannose receptor
CD206. CD206 expression in endothelial cells has been
previously reported to be linked to the phagocytic activity of
this cell type (61). In addition, Awert et al. describe CD206
as a marker for perivascular macrophages and show that
they locate closely to Emcn+ cells in tumors (62). CD206+
endothelial cells can be found in different tissues such as the
liver (63, 64) or placenta (61). Future experiments need to be
performed to investigate the cellular origin of the CD206 signal
we observe.
In tissue areas adjacent of the fracture gap, an inhomogeneous
distribution of macrophages, as well as endothelia toward
the distal end of the femur (spatial polarization), is evident.
We suspect that the osteotomy, which interrupts all
vessels in the tissue, in combination with placement of
the neighboring, distal screw (one of four screws) creates
damage to the blood supply occurring from both sides of
the fracture (Supplementary Figure 6). Large veins and the
main sinus exit the bone at few points. However, trans-
cortical vessels are predominantly responsible for the arterial
blood supply in long bones, as described recently (65).
Since the cortical integrity is disrupted by the osteotomy
and the screw placement, the blood supply is disturbed
to a high degree in a complete osteotomy model. We
assume that this results in extensive tissue damage, which
in turn initiates the recruitment of macrophages followed
by vascularization, leading to the observed phenomenon of
transient distal polarization.
Taken together, we demonstrate here that type H endothelium
is present throughout the regeneration in standardized
osteotomy models in mice. Osx+ osteoblasts as well as
macrophages are present in close proximity to the vasculature,
indicating an important crosstalk. M2-like macrophages are
mainly found in extramedullar regions, with no obvious
interconnection to the vasculature. In addition, we describe
CX3CR1+F4/80+ cells to be the predominant macrophage
population, which progressively infiltrates the hematoma. These
macrophages precede perfused vascularization in the first phase
of vascularization and reside there until remodeling takes place.
A strong polarization of type H endothelium as well as of
macrophages distally to the fracture gap is found in the fracture
models. Our findings underline the importance of the innate
immune system within the bone regeneration process by linking
myeloid cells present in the fracture gap to local angiogenesis.
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